|
CLRB Cellectar Biosciences Inc 1279704 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-6,930,653.00 |
| Balance Sheet |
|
Current Assets
|
$34,877,641.00 |
|
Assets
|
$36,639,086.00 |
|
Current Liabilities
|
$5,237,711.00 |
|
Liabilities
|
$6,767,253.00 |
|
Equity
|
$29,871,833.00 |
|
Shares Out
|
8252108.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-10,855,742.00 |
|
Investing Cash Flow
|
$-3,378.00 |
| Market Analysis |
Market Cap
|
$21,372,959.72 |
|
Price
|
$2.59 |
|
BVPS
|
3.62 |
|
PB
|
0.72 |
|
EPS
|
-0.57 |
|
FCF
|
$-10,859,120.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:58 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:48 |
|
| Apr |
May |
Jun |
| 2026-03-04 |
-8.35 |
|
|
2026-05-14 |
-1.33 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-3.39 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-1.41 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CLRB documents filed with the SEC.
CLRB Filings
Clear
